- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 235/02 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
Patent holdings for IPC class C07D 235/02
Total number of patents in this class: 411
10-year publication summary
|
18
|
36
|
37
|
35
|
36
|
23
|
12
|
23
|
16
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Gruenenthal GmbH | 110 |
16 |
| Glaxo Group Limited | 4283 |
11 |
| LG Chem, Ltd. | 17632 |
10 |
| AstraZeneca AB | 2961 |
10 |
| Boehringer Ingelheim International GmbH | 4756 |
10 |
| The Regents of the University of California | 19493 |
9 |
| Vitae Pharmaceuticals, Inc. | 97 |
9 |
| Allergan, Inc. | 2445 |
7 |
| President and Fellows of Harvard College | 5905 |
7 |
| Reata Pharmaceuticals, Inc. | 122 |
7 |
| The University of Queensland | 656 |
7 |
| BASF SE | 20387 |
6 |
| Grünenthal GmbH | 599 |
6 |
| Ligand Pharmaceuticals Incorporated | 119 |
6 |
| The Provost, Fellows, Foundation Scholars, and The Other Members of Board, of The College of The Holy and Undivided Trinity of Queen Elizabeth, Near Dublin | 160 |
6 |
| Bristol-myers Squibb Company | 4883 |
5 |
| Merck Sharp & Dohme Corp. | 2219 |
5 |
| Medshine Discovery Inc. | 610 |
5 |
| Memorial Sloan-Kettering Cancer Center | 1885 |
5 |
| Janssen Pharmaceutica N.V. | 3624 |
4 |
| Other owners | 260 |